clinical data
DOJ Asks Court to Dismiss Lawsuit Against Xlear
On March 10, the Department of Justice (DOJ) asked the United States District Court of Utah to dismiss the Federal Trade Commission (FTC)’s lawsuit against Xlear (American Fork, UT) and its CEO Nathan Jones. In October 2021, FTC filed a lawsuit against Xlear and Jones alleging the company’s statements that its nasal spray could serve ...
FDA Releases New Guidance on Oral Phenylephrine, Xlear Responds
On Nov. 7, the U.S. Food and Drug Administration (FDA) proposed removing oral phenylephrine from over the counter (OTC) medications due to “effectiveness concerns.” According to FDA, oral phenylephrine is widely used as an active ingredient in nasal decongestants. The agency conducted a comprehensive review of all available data on the safety and efficacy of ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Vitamin Retailer magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listing:
Subscribe To Our Newsletter
Stay Informed! Breaking news, industry trends featured topics, and more.
Subscribe to our newsletter today!